CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES:
Consolidated net income	$ 111,349	$ 30,270
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred tax (benefit) expense	1,378	(11,354)
Depreciation and amortization	24,973	15,051
Programming expenses	252,368	224,491
Stock based compensation expense	3,157	5,352
Equity in income of unconsolidated investees	(840)	(657)
Foreign currency gains	(1,187)	(1,666)
Impairment loss		82,503
Changes in operating assets and liabilities:
Trade accounts receivable	(7,903)	(13,024)
Prepayments	957	(3,594)
Other assets	(5,819)	(11,270)
Accounts payable and accrued liabilities	(4,513)	14,150
Deferred revenue	(914)	5,994
Other liabilities	(26,721)	(7,600)
Dividends received from equity investees	707	485
Acquisition of programming and sublicensing rights	(282,487)	(272,158)
Net cash provided by operating activities	64,505	56,973
CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisitions of property and equipment and intangible assets	(3,548)	(9,437)
Acquisitions of businesses, net of cash acquired	(461)	(2,683)
Receipts from deposits, net	26,219	39,014
Net cash provided by investing activities	22,210	26,894
CASH FLOWS FROM FINANCING ACTIVITIES:
Repurchases of common stock	(29,727)
Proceeds from exercise of stock options	454	4,615
Settlements of overdraft and loans, net	(3,587)	(10,756)
Dividends paid to stockholders	(73,854)	(61,683)
Dividends paid to non-controlling interest	(4,795)	(4,195)
Net cash used in financing activities	(111,509)	(72,019)
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	(2,613)	(178)
Net increase/(decrease) in cash and cash equivalents	(27,407)	11,670
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	55,181	12,331
CASH AND CASH EQUIVALENTS AT END OF PERIOD	$ 27,774	$ 24,001